APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidepressants

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antidepressants Market Outlook and Growth Opportunities 2026

30 December 2025199 pages

Choose your research edition.

Industry ResearchAntidepressants Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidepressants Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Antidepressants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidepressants Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidepressants Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Antidepressants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antidepressants market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antidepressants market include Bristol-Myers Squibb Company, H Lundbeck, Sun Pharmaceuticals, Astrazeneca, GlaxoSmithKline, Pfizer Inc., Eli Lilly and Company, Merck and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antidepressants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidepressants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidepressants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antidepressants market size, projected growth trends, production technologies, key applications, and end-use industries.

Antidepressants Segment by Company

Bristol-Myers Squibb Company

H Lundbeck

Sun Pharmaceuticals

Astrazeneca

GlaxoSmithKline

Pfizer Inc.

Eli Lilly and Company

Merck

Johnson & Johnson

Sanofi

Antidepressants Segment by Type

Benzodiazepines

Monoamine Oxidase Inhibitors

Antipsychotics

Tricyclic Antidepressants

Novel Agents

Selective Norepinephrine Reuptake Inhibitors

Selective Serotonin Reuptake Inhibitors

Antidepressants Segment by Application

Hospitals

Clinics

Other

Antidepressants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antidepressants status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antidepressants market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antidepressants significant trends, drivers, influence factors in global and regions.

6. To analyze Antidepressants competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidepressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidepressants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidepressants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antidepressants market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antidepressants industry.

Chapter 3: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antidepressants in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antidepressants Industry Trends Table 2. Antidepressants Industry Drivers Table 3. Antidepressants Industry Opportunities and Challenges Table 4. Antidepressants Industry Restraints Table 5. Global Antidepressants Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antidepressants Revenue Share by Company (2021-2026) Table 7. Global Antidepressants Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Antidepressants Sales Volume Share by Company (2021-2026) Table 9. Global Antidepressants Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antidepressants Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antidepressants Key Company Manufacturing Base & Headquarters Table 12. Global Antidepressants Company, Product Type & Application Table 13. Global Antidepressants Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antidepressants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Benzodiazepines Table 18. Significant Companies of Monoamine Oxidase Inhibitors Table 19. Significant Companies of Antipsychotics Table 20. Significant Companies of Tricyclic Antidepressants Table 21. Significant Companies of Novel Agents Table 22. Significant Companies of Selective Norepinephrine Reuptake Inhibitors Table 23. Significant Companies of Selective Serotonin Reuptake Inhibitors Table 24. Global Antidepressants Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Antidepressants Sales Volume by Type (2021-2026) & (W Units) Table 26. Global Antidepressants Sales Volume by Type (2027-2032) & (W Units) Table 27. Global Antidepressants Sales Volume Share by Type (2021-2026) Table 28. Global Antidepressants Sales Volume Share by Type (2027-2032) Table 29. Global Antidepressants Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Antidepressants Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Antidepressants Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Antidepressants Sales Value Share by Type (2021-2026) Table 33. Global Antidepressants Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Hospitals Table 35. Significant Companies of Clinics Table 36. Significant Companies of Other Table 37. Global Antidepressants Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Antidepressants Sales Volume by Application (2021-2026) & (W Units) Table 39. Global Antidepressants Sales Volume by Application (2027-2032) & (W Units) Table 40. Global Antidepressants Sales Volume Share by Application (2021-2026) Table 41. Global Antidepressants Sales Volume Share by Application (2027-2032) Table 42. Global Antidepressants Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Antidepressants Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Antidepressants Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Antidepressants Sales Value Share by Application (2021-2026) Table 46. Global Antidepressants Sales Value Share by Application (2027-2032) Table 47. Global Antidepressants Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Antidepressants Sales by Region (2021-2026) & (W Units) Table 49. Global Antidepressants Sales Market Share by Region (2021-2026) Table 50. Global Antidepressants Sales by Region (2027-2032) & (W Units) Table 51. Global Antidepressants Sales Market Share by Region (2027-2032) Table 52. Global Antidepressants Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Antidepressants Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Antidepressants Sales Value Share by Region (2021-2026) Table 55. Global Antidepressants Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Antidepressants Sales Value Share by Region (2027-2032) Table 57. Global Antidepressants Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Antidepressants Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Antidepressants Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. Global Antidepressants Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Antidepressants Sales by Country (2021-2026) & (W Units) Table 62. Global Antidepressants Sales Market Share by Country (2021-2026) Table 63. Global Antidepressants Sales by Country (2027-2032) & (W Units) Table 64. Global Antidepressants Sales Market Share by Country (2027-2032) Table 65. Global Antidepressants Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Antidepressants Sales Value Market Share by Country (2021-2026) Table 67. Global Antidepressants Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Antidepressants Sales Value Market Share by Country (2027-2032) Table 69. Bristol-Myers Squibb Company Company Information Table 70. Bristol-Myers Squibb Company Business Overview Table 71. Bristol-Myers Squibb Company Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bristol-Myers Squibb Company Antidepressants Product Portfolio Table 73. Bristol-Myers Squibb Company Recent Development Table 74. H Lundbeck Company Information Table 75. H Lundbeck Business Overview Table 76. H Lundbeck Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. H Lundbeck Antidepressants Product Portfolio Table 78. H Lundbeck Recent Development Table 79. Sun Pharmaceuticals Company Information Table 80. Sun Pharmaceuticals Business Overview Table 81. Sun Pharmaceuticals Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sun Pharmaceuticals Antidepressants Product Portfolio Table 83. Sun Pharmaceuticals Recent Development Table 84. Astrazeneca Company Information Table 85. Astrazeneca Business Overview Table 86. Astrazeneca Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Astrazeneca Antidepressants Product Portfolio Table 88. Astrazeneca Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Antidepressants Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Pfizer Inc. Company Information Table 95. Pfizer Inc. Business Overview Table 96. Pfizer Inc. Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Inc. Antidepressants Product Portfolio Table 98. Pfizer Inc. Recent Development Table 99. Eli Lilly and Company Company Information Table 100. Eli Lilly and Company Business Overview Table 101. Eli Lilly and Company Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Eli Lilly and Company Antidepressants Product Portfolio Table 103. Eli Lilly and Company Recent Development Table 104. Merck Company Information Table 105. Merck Business Overview Table 106. Merck Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Merck Antidepressants Product Portfolio Table 108. Merck Recent Development Table 109. Johnson & Johnson Company Information Table 110. Johnson & Johnson Business Overview Table 111. Johnson & Johnson Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Johnson & Johnson Antidepressants Product Portfolio Table 113. Johnson & Johnson Recent Development Table 114. Sanofi Company Information Table 115. Sanofi Business Overview Table 116. Sanofi Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sanofi Antidepressants Product Portfolio Table 118. Sanofi Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Antidepressants Distributors List Table 122. Antidepressants Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Antidepressants Product Image Figure 2. Global Antidepressants Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidepressants Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antidepressants Sales (2021-2032) & (W Units) Figure 5. Global Antidepressants Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antidepressants Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Benzodiazepines Image Figure 10. Monoamine Oxidase Inhibitors Image Figure 11. Antipsychotics Image Figure 12. Tricyclic Antidepressants Image Figure 13. Novel Agents Image Figure 14. Selective Norepinephrine Reuptake Inhibitors Image Figure 15. Selective Serotonin Reuptake Inhibitors Image Figure 16. Global Antidepressants Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Antidepressants Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Antidepressants Sales Volume Share by Type (2021-2032) Figure 19. Global Antidepressants Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antidepressants Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Antidepressants Sales Value Share by Type (2021-2032) Figure 22. Hospitals Image Figure 23. Clinics Image Figure 24. Other Image Figure 25. Global Antidepressants Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Antidepressants Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Antidepressants Sales Volume Share by Application (2021-2032) Figure 28. Global Antidepressants Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Antidepressants Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Antidepressants Sales Value Share by Application (2021-2032) Figure 31. Global Antidepressants Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 32. Global Antidepressants Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Antidepressants Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Antidepressants Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Antidepressants Sales Value (2021-2032) & (US$ Million) Figure 36. North America Antidepressants Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Antidepressants Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Antidepressants Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Antidepressants Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Antidepressants Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Antidepressants Sales Value (2021-2032) & (US$ Million) Figure 42. South America Antidepressants Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Antidepressants Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Antidepressants Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Antidepressants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Antidepressants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Antidepressants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Antidepressants Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Antidepressants Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Benzodiazepines
  • Monoamine Oxidase Inhibitors
  • Antipsychotics
  • Tricyclic Antidepressants
  • Novel Agents
  • Selective Norepinephrine Reuptake Inhibitors
  • Selective Serotonin Reuptake Inhibitors
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Bristol-Myers Squibb Company
  • H Lundbeck
  • Sun Pharmaceuticals
  • Astrazeneca
  • GlaxoSmithKline
  • Pfizer Inc.
  • Eli Lilly and Company
  • Merck
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidepressants Sales Value (2021-2032)
  4. 1.2.2 Global Antidepressants Sales Volume (2021-2032)
  5. 1.2.3 Global Antidepressants Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antidepressants Market Dynamics
  1. 2.1 Antidepressants Industry Trends
  2. 2.2 Antidepressants Industry Drivers
  3. 2.3 Antidepressants Industry Opportunities and Challenges
  4. 2.4 Antidepressants Industry Restraints
3 Antidepressants Market by Company
  1. 3.1 Global Antidepressants Company Revenue Ranking in 2025
  2. 3.2 Global Antidepressants Revenue by Company (2021-2026)
  3. 3.3 Global Antidepressants Sales Volume by Company (2021-2026)
  4. 3.4 Global Antidepressants Average Price by Company (2021-2026)
  5. 3.5 Global Antidepressants Company Ranking (2024-2026)
  6. 3.6 Global Antidepressants Company Manufacturing Base and Headquarters
  7. 3.7 Global Antidepressants Company Product Type and Application
  8. 3.8 Global Antidepressants Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antidepressants Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antidepressants Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antidepressants Market by Type
  1. 4.1 Antidepressants Type Introduction
  2. 4.1.1 Benzodiazepines
  3. 4.1.2 Monoamine Oxidase Inhibitors
  4. 4.1.3 Antipsychotics
  5. 4.1.4 Tricyclic Antidepressants
  6. 4.1.5 Novel Agents
  7. 4.1.6 Selective Norepinephrine Reuptake Inhibitors
  8. 4.1.7 Selective Serotonin Reuptake Inhibitors
  9. 4.2 Global Antidepressants Sales Volume by Type
  10. 4.2.1 Global Antidepressants Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Antidepressants Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Antidepressants Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Antidepressants Sales Value by Type
  14. 4.3.1 Global Antidepressants Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Antidepressants Sales Value by Type (2021-2032)
  16. 4.3.3 Global Antidepressants Sales Value Share by Type (2021-2032)
5 Antidepressants Market by Application
  1. 5.1 Antidepressants Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Antidepressants Sales Volume by Application
  6. 5.2.1 Global Antidepressants Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antidepressants Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Antidepressants Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Antidepressants Sales Value by Application
  10. 5.3.1 Global Antidepressants Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antidepressants Sales Value by Application (2021-2032)
  12. 5.3.3 Global Antidepressants Sales Value Share by Application (2021-2032)
6 Antidepressants Regional Sales and Value Analysis
  1. 6.1 Global Antidepressants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antidepressants Sales by Region (2021-2032)
  3. 6.2.1 Global Antidepressants Sales by Region: 2021-2026
  4. 6.2.2 Global Antidepressants Sales by Region (2027-2032)
  5. 6.3 Global Antidepressants Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antidepressants Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antidepressants Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antidepressants Sales Value by Region (2027-2032)
  9. 6.5 Global Antidepressants Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antidepressants Sales Value (2021-2032)
  12. 6.6.2 North America Antidepressants Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antidepressants Sales Value (2021-2032)
  15. 6.7.2 Europe Antidepressants Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antidepressants Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antidepressants Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antidepressants Sales Value (2021-2032)
  21. 6.9.2 South America Antidepressants Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antidepressants Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antidepressants Sales Value Share by Country, 2025 VS 2032
7 Antidepressants Country-level Sales and Value Analysis
  1. 7.1 Global Antidepressants Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antidepressants Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antidepressants Sales by Country (2021-2032)
  4. 7.3.1 Global Antidepressants Sales by Country (2021-2026)
  5. 7.3.2 Global Antidepressants Sales by Country (2027-2032)
  6. 7.4 Global Antidepressants Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antidepressants Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antidepressants Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antidepressants Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antidepressants Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antidepressants Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antidepressants Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antidepressants Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antidepressants Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antidepressants Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antidepressants Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antidepressants Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antidepressants Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antidepressants Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antidepressants Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antidepressants Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antidepressants Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antidepressants Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antidepressants Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antidepressants Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antidepressants Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antidepressants Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antidepressants Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antidepressants Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antidepressants Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antidepressants Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antidepressants Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antidepressants Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antidepressants Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antidepressants Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antidepressants Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antidepressants Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antidepressants Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antidepressants Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antidepressants Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antidepressants Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antidepressants Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antidepressants Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antidepressants Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antidepressants Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antidepressants Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antidepressants Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antidepressants Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antidepressants Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antidepressants Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antidepressants Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antidepressants Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antidepressants Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antidepressants Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antidepressants Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antidepressants Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antidepressants Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antidepressants Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antidepressants Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antidepressants Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antidepressants Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antidepressants Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antidepressants Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antidepressants Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antidepressants Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antidepressants Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antidepressants Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antidepressants Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antidepressants Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antidepressants Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antidepressants Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antidepressants Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antidepressants Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antidepressants Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antidepressants Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antidepressants Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antidepressants Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antidepressants Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antidepressants Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antidepressants Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antidepressants Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antidepressants Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antidepressants Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antidepressants Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antidepressants Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antidepressants Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antidepressants Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antidepressants Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antidepressants Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antidepressants Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antidepressants Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antidepressants Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol-Myers Squibb Company
  2. 8.1.1 Bristol-Myers Squibb Company Company Information
  3. 8.1.2 Bristol-Myers Squibb Company Business Overview
  4. 8.1.3 Bristol-Myers Squibb Company Antidepressants Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bristol-Myers Squibb Company Antidepressants Product Portfolio
  6. 8.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 8.2 H Lundbeck
  8. 8.2.1 H Lundbeck Company Information
  9. 8.2.2 H Lundbeck Business Overview
  10. 8.2.3 H Lundbeck Antidepressants Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 H Lundbeck Antidepressants Product Portfolio
  12. 8.2.5 H Lundbeck Recent Developments
  13. 8.3 Sun Pharmaceuticals
  14. 8.3.1 Sun Pharmaceuticals Company Information
  15. 8.3.2 Sun Pharmaceuticals Business Overview
  16. 8.3.3 Sun Pharmaceuticals Antidepressants Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceuticals Antidepressants Product Portfolio
  18. 8.3.5 Sun Pharmaceuticals Recent Developments
  19. 8.4 Astrazeneca
  20. 8.4.1 Astrazeneca Company Information
  21. 8.4.2 Astrazeneca Business Overview
  22. 8.4.3 Astrazeneca Antidepressants Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Astrazeneca Antidepressants Product Portfolio
  24. 8.4.5 Astrazeneca Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Antidepressants Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Antidepressants Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Pfizer Inc.
  32. 8.6.1 Pfizer Inc. Company Information
  33. 8.6.2 Pfizer Inc. Business Overview
  34. 8.6.3 Pfizer Inc. Antidepressants Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Inc. Antidepressants Product Portfolio
  36. 8.6.5 Pfizer Inc. Recent Developments
  37. 8.7 Eli Lilly and Company
  38. 8.7.1 Eli Lilly and Company Company Information
  39. 8.7.2 Eli Lilly and Company Business Overview
  40. 8.7.3 Eli Lilly and Company Antidepressants Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly and Company Antidepressants Product Portfolio
  42. 8.7.5 Eli Lilly and Company Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Antidepressants Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merck Antidepressants Product Portfolio
  48. 8.8.5 Merck Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Antidepressants Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Antidepressants Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Antidepressants Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Antidepressants Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antidepressants Value Chain Analysis
  2. 9.1.1 Antidepressants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antidepressants Sales Mode & Process
  6. 9.2 Antidepressants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antidepressants Distributors
  9. 9.2.3 Antidepressants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst